NeoVista's Series E Round

NeoVista raised a round of funding on May 14, 2012.

NeoVista is developing medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). The company's technology utilizes highly targeted strontium 90 beta radiat…

Articles about NeoVista's Series E Round: